×
About 1,873 results

ALLMedicine™ Chickenpox Center

Research & Reviews  298 results

Paediatric erythema multiforme: not every bullous rash is chickenpox.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719153
BMJ Case Reports; Lança A, Bernardo M et. al.

Jan 1st, 2022 - Paediatric erythema multiforme: not every bullous rash is chickenpox.|2022|Lança A,Bernardo M,Pinto S,|

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
https://clinicaltrials.gov/ct2/show/NCT05084508

Dec 30th, 2021 - The purpose of this study is to assess immune response and safety of various potencies of an investigational chickenpox vaccine given to healthy children 12 to 15 months of age.

Risk factors for some tropical diseases in an African country.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666074
BMC Public Health; Uzoka FE, Akwaowo C et. al.

Dec 14th, 2021 - Often, non-clinical risk factors could affect the predisposition of an individual to diseases. Understanding these factors and their impacts helps in disease prevention and control. This study identified risk factors for malaria, yellow fever, typ...

Vaccines for measles, mumps, rubella, and varicella in children.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336
The Cochrane Database of Systematic Reviews; Di Pietrantonj C, Rivetti A et. al.

Nov 23rd, 2021 - Measles, mumps, rubella, and varicella (chickenpox) are serious diseases that can lead to serious complications, disability, and death. However, public debate over the safety of the trivalent MMR vaccine and the resultant drop in vaccination cover...

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
https://clinicaltrials.gov/ct2/show/NCT02538341

Nov 23rd, 2021 - Herpes zoster (HZ), also known as "shingles", is caused by reactivation and multiplication of the ubiquitous varicella zoster virus (VZV) that remains latent in everyone's sensory neurons following varicella, or "chickenpox". Among individuals who...

see more →

Drugs  304 results see all →

Clinicaltrials.gov  18 results

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
https://clinicaltrials.gov/ct2/show/NCT05084508

Dec 30th, 2021 - The purpose of this study is to assess immune response and safety of various potencies of an investigational chickenpox vaccine given to healthy children 12 to 15 months of age.

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
https://clinicaltrials.gov/ct2/show/NCT02538341

Nov 23rd, 2021 - Herpes zoster (HZ), also known as "shingles", is caused by reactivation and multiplication of the ubiquitous varicella zoster virus (VZV) that remains latent in everyone's sensory neurons following varicella, or "chickenpox". Among individuals who...

Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines
https://clinicaltrials.gov/ct2/show/NCT04751695

Feb 12th, 2021 - Coronavirus-2019 (COVID-19) is a global epidemic that has serious consequences and affects the world with its rapid spread and high mortality rate. The number of people infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2) is r...

Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019
https://clinicaltrials.gov/ct2/show/NCT04609774

Feb 4th, 2021 - The Corona Virus Disease 2019 is rapidly spreading throughout the world. Aerosol is a potential transmission route. The transmission of severe acute respiratory syndrome coronavirus in humans is thought to be via at least 3 sources: 1) inhalation ...

Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)
https://clinicaltrials.gov/ct2/show/NCT01623271

Jul 23rd, 2020 - This research is being conducted to see if the drug Gralise can help people with Complex Regional Pain Syndrom Type I (CRPS I) without causing too many side effects. CRPS I is one of the most common conditions of neuropathic pain (pain that result...

see more →

News  93 results

Schools, pediatricians look to make up lost ground on non–COVID-19 vaccinations
https://www.mdedge.com/pediatrics/article/249017/vaccines/schools-pediatricians-look-make-lost-ground-non-covid-19
Kate Ruder, Kaiser Health News

Nov 22nd, 2021 - WESTMINSTER, COLO. – Melissa Blatzer was determined to get her three children caught up on their routine immunizations on a recent Saturday morning at a walk-in clinic in this Denver suburb.

ACIP Recommends Shingrix for Younger Immunocompromised Adults; Updates Pneumococcal Vaccine Guidance
https://www.medscape.com/viewarticle/961385

Oct 21st, 2021 - The US Centers for Disease Control and Prevention Advisory Committee of Immunization Practices (ACIP) has voted to recommend Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in immunodeficient or imm...

COVID Immunity Through Infection or Vaccination: Are They Equal?
https://www.medscape.com/viewarticle/960533

Oct 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Dr. Aaron Kheriaty, a University of California-Irvine psychiatry professor, felt he didn’t need to be vaccinated against covid because he’d fallen...

Hard-Won Gains at Risk as Delta Variant Spreads: WHO
https://www.medscape.com/viewarticle/955743

Aug 2nd, 2021 - GENEVA (Reuters) — The world is at risk of losing hard-won gains in fighting COVID-19, as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective against the disease, the World Health Organization said on Friday....

Shingrix OK'd for Immunocompromised Adults
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/93760

Jul 26th, 2021 - FDA expanded the approval of Shingrix, an adjuvanted recombinant zoster vaccine, for adults at increased risk of shingles due to immunosuppression, manufacturer GlaxoSmithKline (GSK) announced on Monday. The expanded indication is for adults ages ...

see more →

Patient Education  36 results see all →